WallStreetZenWallStreetZen

NASDAQ: RDHL
Redhill Biopharma Ltd Earnings Dates, Reports, Calls

OverviewEarnings
RevenueDividendOwnership
Redhill Biopharma earnings were -$8.3M for the trailing 12 months ending Dec 31, 2024, with -100% growth year over year. The latest RDHL earnings report on Dec 31, 2024 announced Q4 2024 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, RDHL reported annual earnings of -$8.3M, with -134.6% growth.

RDHL past earnings growth

How has RDHL's earnings growth performed historically?

Company
-100%
Industry
55.51%
Market
64.34%
RDHL's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
RDHL's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance

RDHL earnings history

Current Revenue
$8.0M
Current Earnings
-$8.3M
Current Profit Margin
-102.8%

RDHL Return on Equity

Current Company
N/A
Current Industry
12.5%
Current Market
34.1%

RDHL undefined

Current Company
-40.2%
Current Industry
5.5%
RDHL is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when RDHL announces earnings.

RDHL undefined

Current Company
349.59%
Current Industry
12%
RDHL has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

RDHL vs Pharmaceutical Stocks

TickerEBITDAEarningsY/Y EarningsEPS
RDHL-$13.99M-$8.27M-100.00%$0.00
UPC-$15.83M-$18.55MN/A-$3,054.00
PTPI-$10.81M-$26.80MN/A-$3.34
SHPH-$7.93M-$9.14MN/A-$3.19
YCBD-$1.09M-$6.69MN/A-$1.67
View Top Pharmaceutical Stocks

Redhill Biopharma Earnings Reports & History FAQ

What were Redhill Biopharma's earnings last quarter?

Redhill Biopharma (NASDAQ: RDHL) reported Q4 2024 earnings per share (EPS) of N/A, up N/A year over year. Total RDHL earnings for the quarter were N/A. In the same quarter last year, Redhill Biopharma's earnings per share (EPS) was N/A.

If you're new to stock investing, here's how to buy Redhill Biopharma stock.

Is Redhill Biopharma profitable or losing money?

As of the last Redhill Biopharma earnings report, Redhill Biopharma is currently losing money. Redhill Biopharma's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$8.27 million, a 134.57% decrease year over year.

What was RDHL's earnings growth in the past year?

As of Redhill Biopharma's earnings date in Q2 2025, Redhill Biopharma's earnings has grown -100% year over year. This is 155.51 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry earnings growth rate of 55.51%. RDHL earnings in the past year totalled -$8.27 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.